PRISMA for Targeting Mutant IDH in Glioma: Mechanistic Insights and Clinical Implications of Vorasidenib

Description

This data contains the PRISMA checklist and flowchart showing the systematic reviews eligibility according to PRISMA guidelines as well as a summarization of the screening process.

Institutions

• Airlangga University

  East Java, Surabaya

Categories

Licence